Abstract
The supernatant fraction of centrifuged homogenate of brain tissue contains material that inhibits the saturable binding of [3H]cocaine to crude mouse brain membranes. This material was subjected to heat treatment to remove protein; further purification was achieved by filtering through an Amicon UM-10 membrane ultrafilter and gel filtration of the ultrafiltrate on Sephadex G-25. Sensitivity to acid hydrolysis and peptidase action indicates that the inhibitory activity resides in peptide material with a low molecular weight. The partially purified inhibitor has similar effects to that of cocaine on the specific binding of various ligands to opiate and nonopiate receptors in mouse brain membranes.
Similar content being viewed by others
References
Reith, M. E. A., Sershen, H., andLajtha, A. 1980. Saturable [3H]cocaine binding in central nervous system of mouse Life Sci. 27:1055–1062.
Sershen, H., Reith, M. E. A., andLajtha, A. 1980. The pharmacological relevance of the cocaine binding site in mouse brain. Neuropharmacol. 19:1145–1148.
Clarke, R. L., Daum, S. J., Gambino, A. J., Aceto, M. D., Pearl, J., Levitt, M., Cumiskey, W. R., andBogado, E. F. 1973. Compounds affecting the central nervous system. 4, 3β-phenyltropane-2-carboxylic esters and analogs. J. Med. Chem. 16:1260–1267.
Spealman, R. D., andKelleher, R. T. 1980. Self-administration of cocaine derivatives by squirrel monkeys. Fed. Proc. 39:404.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., andRandall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.
Smith, E. L., andPackman, D. H. 1955. Leucine aminopeptidase. V. Activation, specificity and mechanism of action. J. Biol. Chem. 212:271–299.
Creese, I., Prosser, T., andSnyder, S. H. 1978. Dopamine receptor binding: Specificity, localization and regulation by ions and guanyl nucleotides. Life Sci. 23:495–500.
Misra, A. L., Nayak, P. K., Patel, M. N., Vadlamani, N. L., andMulé, S. J. 1974. Identification of norcocaine as a metabolite of [3H]cocaine in rat brain. Experientia 30:1312–1314.
Woods, L. A., McMahon, F. G., andSeevers, M. H. 1951. Distribution and metabolism of cocaine in the dog and rabbit. J. Pharm. Exp. Ther. 101:200–204.
VanDyke, C., Barash, P. G., Jatlow, P., andByck, R. 1976. Cocaine: Plasma concentrations after intranasal application in man. Science 191:859–861.
Pasternak, G. W., Goodman, R., andSnyder, S. H. 1975. An endogenous morphinelike factor in mammalian brain. Life Sci. 16:1765–1769.
Terenius, L., andWahlström, A. 1975. Morphine-like ligand for opiate receptors in human CSF. Life Sci. 16:1759–1764.
Toffano, G., Guidotti, A., andCosta, E. 1978. Purification of an endogenous protein inhibitor of the high affinity binding of γ-aminobutyric acid to synaptic membranes of rat brain. Proc. Natl. Acad. Sci. U.S.A. 75:4024–4028.
Davis, L. G., andCohen, R. K. 1980. Identification of an endogenous peptide-ligand for the benzodiazepine receptor. Biochem. Biophys. Res. Commun. 92:141–148.
Wajda, I. J., Neidle, A., Ehrenpreis, S., andManigault, I. 1976. Properties and distribution of morphine-like substances. Pages 129–136,in Kosterlitz, H. W. (ed.), Opiates and Endogenous Opioid Peptides, Elsevier, Amsterdam.
Craviso, G. L., andMusacchio, J. M. 1975. Competitive inhibition of stereospecific opiate binding by local anesthetics in mouse brain. Life Sci. 16:1803–1808.
Neidle, A., Manigault, I., andWajda, I. J. 1979. Distribution of opiate-like substances in rat tissues. Neurochem. Res. 4:399–410.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reith, M.E.A., Sershen, H. & Lajtha, A. Endogenous peptide(s) inhibiting [3H]cocaine binding in mouse brain. Neurochem Res 5, 1291–1299 (1980). https://doi.org/10.1007/BF00964964
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00964964